Page last updated: 2024-09-05

sorafenib and pd 198306

sorafenib has been researched along with pd 198306 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(pd 198306)
Trials
(pd 198306)
Recent Studies (post-2010) (pd 198306)
6,5207305,251705

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, X; Hong, J; Zheng, W1

Other Studies

1 other study(ies) available for sorafenib and pd 198306

ArticleYear
Small-molecule High-throughput Screening Identifies an MEK Inhibitor PD198306 that Enhances Sorafenib Efficacy via MCL-1 and BIM in Hepatocellular Carcinoma Cells.
    Combinatorial chemistry & high throughput screening, 2023, Volume: 26, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Bcl-2-Like Protein 11; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; High-Throughput Screening Assays; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Sorafenib

2023